Stock Price, News, Quote and Profile of ZIVO BIOSCIENCE INC(NASDAQ:ZIVO) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ZIVO BIOSCIENCE INC

NASDAQ:ZIVO (11/24/2023, 7:12:49 PM)

After market: 1.12 +0.02 (+1.82%)

1.1

-0.05 (-4.35%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorConsumer Staples

GICS IndustryPersonal Care Products

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap1.91M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Zivo Bioscience Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Bloomfield Hills, Michigan and currently employs 8 full-time employees. The company went IPO on 2000-10-06. Zivo Bioscience, Inc. is a research and development company. The firm operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modification, Algal biomass for human consumption and Biomass for supporting skin health / anti-aging. The firm is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers. Its product candidates are at different stages of development for different applications.